181 related articles for article (PubMed ID: 34663825)
21. Elevation of ADAM12 facilitates tumor progression by enhancing metastasis and immune infiltration in gastric cancer.
Zhu H; Jiang W; Zhu H; Hu J; Tang B; Zhou Z; He X
Int J Oncol; 2022 May; 60(5):. PubMed ID: 35315496
[TBL] [Abstract][Full Text] [Related]
22. Exosomal miRNAs from Peritoneum Lavage Fluid as Potential Prognostic Biomarkers of Peritoneal Metastasis in Gastric Cancer.
Tokuhisa M; Ichikawa Y; Kosaka N; Ochiya T; Yashiro M; Hirakawa K; Kosaka T; Makino H; Akiyama H; Kunisaki C; Endo I
PLoS One; 2015; 10(7):e0130472. PubMed ID: 26208314
[TBL] [Abstract][Full Text] [Related]
23. LINC00319 acts as a
Zou J; Wu K; Lin C; Jie ZG
Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G10-G22. PubMed ID: 31433213
[TBL] [Abstract][Full Text] [Related]
24. MiR-129-5p functions as a tumor suppressor in gastric cancer progression through targeting ADAM9.
Liu Q; Jiang J; Fu Y; Liu T; Yu Y; Zhang X
Biomed Pharmacother; 2018 Sep; 105():420-427. PubMed ID: 29879625
[TBL] [Abstract][Full Text] [Related]
25. The clinical significance of miR-335, miR-124, miR-218 and miR-484 downregulation in gastric cancer.
Zare A; Ahadi A; Larki P; Omrani MD; Zali MR; Alamdari NM; Ghaedi H
Mol Biol Rep; 2018 Dec; 45(6):1587-1595. PubMed ID: 30171475
[TBL] [Abstract][Full Text] [Related]
26. BCYRN1 is correlated with progression and prognosis in gastric cancer.
Zhai H; Li Y
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31652309
[TBL] [Abstract][Full Text] [Related]
27. miR-215 promotes cell migration and invasion of gastric cancer by targeting Retinoblastoma tumor suppressor gene 1.
Chen Z; Liu K; Li L; Chen Y; Du S
Pathol Res Pract; 2017 Aug; 213(8):889-894. PubMed ID: 28689850
[TBL] [Abstract][Full Text] [Related]
28. Clinical value of miR-425-5p detection and its association with cell proliferation and apoptosis of gastric cancer.
Zhang Z; Wen M; Guo J; Shi J; Wang Z; Tan B; Zhang G; Zheng X; Zhang A
Pathol Res Pract; 2017 Aug; 213(8):929-937. PubMed ID: 28647207
[TBL] [Abstract][Full Text] [Related]
29. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
Li Y; Li L
J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
[TBL] [Abstract][Full Text] [Related]
30. MiR-652 serves as a prognostic biomarker in gastric cancer and promotes tumor proliferation, migration, and invasion via targeting RORA.
Li J; Zou X
Cancer Biomark; 2019; 26(3):323-331. PubMed ID: 31524147
[TBL] [Abstract][Full Text] [Related]
31. Increased expression of miR-601 is associated with poor prognosis and tumor progression of gastric cancer.
Min C; Zhang A; Qin J
Diagn Pathol; 2019 Sep; 14(1):107. PubMed ID: 31547835
[TBL] [Abstract][Full Text] [Related]
32. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
[TBL] [Abstract][Full Text] [Related]
33. CircRNA circPDSS1 promotes the gastric cancer progression by sponging miR-186-5p and modulating NEK2.
Ouyang Y; Li Y; Huang Y; Li X; Zhu Y; Long Y; Wang Y; Guo X; Gong K
J Cell Physiol; 2019 Jul; 234(7):10458-10469. PubMed ID: 30417526
[TBL] [Abstract][Full Text] [Related]
34. APC gene is modulated by hsa-miR-135b-5p in both diffuse and intestinal gastric cancer subtypes.
Magalhães L; Quintana LG; Lopes DCF; Vidal AF; Pereira AL; D'Araujo Pinto LC; de Jesus Viana Pinheiro J; Khayat AS; Goulart LR; Burbano R; de Assumpção PP; Ribeiro-Dos-Santos Â
BMC Cancer; 2018 Oct; 18(1):1055. PubMed ID: 30376837
[TBL] [Abstract][Full Text] [Related]
35. The comprehensive upstream transcription and downstream targeting regulation network of miRNAs reveal potential diagnostic roles in gastric cancer.
Zhang C; Zhang CD; Liang Y; Wu KZ; Pei JP; Dai DQ
Life Sci; 2020 Jul; 253():117741. PubMed ID: 32360623
[TBL] [Abstract][Full Text] [Related]
36. MiR-769-5p functions as an oncogene by down-regulating RYBP expression in gastric cancer.
Luan PB; Jia XZ; Yao J
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6699-6706. PubMed ID: 32633360
[TBL] [Abstract][Full Text] [Related]
37. MiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis.
Xie J; Tan ZH; Tang X; Mo MS; Liu YP; Gan RL; Li Y; Zhang L; Li GQ
World J Gastroenterol; 2014 Dec; 20(46):17439-47. PubMed ID: 25516656
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of miR-142-5p promotes tumor metastasis through directly regulating CYR61 expression in gastric cancer.
Yan J; Yang B; Lin S; Xing R; Lu Y
Gastric Cancer; 2019 Mar; 22(2):302-313. PubMed ID: 30178386
[TBL] [Abstract][Full Text] [Related]
39. miR-140-5p suppresses the proliferation, migration and invasion of gastric cancer by regulating YES1.
Fang Z; Yin S; Sun R; Zhang S; Fu M; Wu Y; Zhang T; Khaliq J; Li Y
Mol Cancer; 2017 Aug; 16(1):139. PubMed ID: 28818100
[TBL] [Abstract][Full Text] [Related]
40. Clinical value screening, prognostic significance and key pathway identification of miR-204-5p in endometrial carcinoma: A study based on the Cancer Genome Atlas (TCGA), and bioinformatics analysis.
Guo S; Yang J; Wu M; Xiao G
Pathol Res Pract; 2019 May; 215(5):1003-1011. PubMed ID: 30910254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
